Unity Biotechnology
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2009-01-01
- Employees
- 19
- Market Cap
- $28.1M
- Introduction
Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 ...
Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
- First Posted Date
- 2023-08-25
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Unity Biotechnology, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06011798
- Locations
- 🇺🇸
California Retina Consultants, Bakersfield, California, United States
🇺🇸Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States
🇺🇸Salehi Retina Institute Inc., Huntington Beach, California, United States
Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)
- Conditions
- Interventions
- First Posted Date
- 2022-03-11
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Unity Biotechnology, Inc.
- Target Recruit Count
- 51
- Registration Number
- NCT05275205
- Locations
- 🇺🇸
University Retina and Macula Associates, Lemont, Illinois, United States
🇺🇸Valley Retina Institute, McAllen, Texas, United States
🇺🇸Retina Vitreous Associates of Florida, Saint Petersburg, Florida, United States
Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD)
- First Posted Date
- 2021-04-23
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Unity Biotechnology, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT04857996
- Locations
- 🇺🇸
Loma Linda University, Loma Linda, California, United States
🇺🇸The Retina Partners, Encino, California, United States
🇺🇸Salehi Retina Institute Inc., Huntington Beach, California, United States
Safety and Tolerability Study of UBX1325 in Patients With Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration
- Conditions
- Interventions
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2022-03-10
- Lead Sponsor
- Unity Biotechnology, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT04537884
- Locations
- 🇺🇸
Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States
🇺🇸Salehi Retina Institute, Huntington Beach, California, United States
🇺🇸Center for Retina and Macular Disease, Winter Haven, Florida, United States
Long-Term Follow-Up Study of Patients With Osteoarthritis of the Knee Treated With UBX0101 or Placebo
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- Unity Biotechnology, Inc.
- Target Recruit Count
- 161
- Registration Number
- NCT04349956
- Locations
- 🇺🇸
Hassman Research Institute, Berlin, New Jersey, United States
🇺🇸Coastal Clinical Research, LLC., Mobile, Alabama, United States
🇺🇸Fiel Family and Sports Medicine, Tempe, Arizona, United States
A Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Unity Biotechnology, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT04229225
- Locations
- 🇺🇸
Premier Medical Associates, The Villages, Florida, United States
🇺🇸Arcis Healthcare LLC dba Lowcountry Orthopaedics and Sports Medicine, North Charleston, South Carolina, United States
🇺🇸Drug Studies America, Marietta, Georgia, United States
A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee
- First Posted Date
- 2019-10-17
- Last Posted Date
- 2021-12-29
- Lead Sponsor
- Unity Biotechnology, Inc.
- Target Recruit Count
- 183
- Registration Number
- NCT04129944
- Locations
- 🇺🇸
Tucson Orthopaedic Institute, Tucson, Arizona, United States
🇺🇸Charter Research, Lady Lake, Florida, United States
🇺🇸Coastal Clinical Research, LLC., Mobile, Alabama, United States
A Safety and Tolerability Study of UBX0101 in Patients With Osteoarthritis of the Knee
- First Posted Date
- 2018-05-01
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Unity Biotechnology, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT03513016
- Locations
- 🇺🇸
TriWest Research Associates, El Cajon, California, United States
🇺🇸BioSolutions Clinical Research Center, La Mesa, California, United States
🇺🇸Center for Pharmaceutical Research, Kansas City, Missouri, United States
An Exploratory Clinical Study to Investigate Biomarkers of Senescence in Patients With Osteoarthritis of the Knee
- Conditions
- Interventions
- First Posted Date
- 2017-04-04
- Last Posted Date
- 2017-08-01
- Lead Sponsor
- Unity Biotechnology, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03100799
- Locations
- 🇺🇸
The Arthritis Treatment Center, Frederick, Maryland, United States